Investors

Events and Presentations


Events and Presentations

Past Events
April 14, 2021 at 11:00 AM EDT
April 10 - April 15, 2021

Presentation Title: TNFSF14 (LIGHT) Co-Stimulation in Combination with Dual TIGIT/PD1 Checkpoint Inhibition (CPI) Induces Anti-Tumor Immunity in a CPI Acquired Resistance (AR) Model that Shares Transcriptional Similarities to Lung Cancer Patients Who Acquire Resistance to CPI


Presentation Title: Antigen-specific targeting of tissue-resident gamma delta T cells with recombinant butyrophilin heterodimeric fusion proteins

Virtual
March 16, 2021 at 11:20 AM EDT
February 17, 2021 at 12:00 PM EST
January 14, 2021 at 5:20 PM EST
January 11, 2021 at 6:00 AM EST
December 2, 2020 at 1:00 PM EST
November 13, 2020 at 2:15 PM EST
November 12, 2020
Presentation Title: CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade to Bridge Innate and Adaptive Immunity
Virtual
November 11, 2020
Presentation Title: In Vivo Expansion of Gamma Delta (𝛾𝛿) T cells by a CD19-Targeted Butyrophilin Heterodimer Leads to Elimination of Peripheral B cells
Virtual